Abstract
Epidemiological and genetic studies have provided important clues that guide the study of the neurobiological basis and the cause of schizophrenia. Studies have revealed that schizophrenia is heterogeneous in phenomenology [1 2], age of onset [3], response to treatment [4] and outcome [5–[7] and illness course [8]. Consequently, etiological or pathophysiological theories of schizophrenia must account for this heterogeneity. One explanation is that schizophrenia may arise from multiple etiological and pathophysiological processes; prompting references to “the schizophrenias” rather than “schizophrenia”. Alternatively, this heterogeneity may be due to a common etiological process, and the variable disease expression due to neurobiological differences that act as modifying factors in affected individuals, or to altered disease expression due to environmental factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Reference
Andreasen, N.C. (1997) Schizophr.Res. 28, 105–109.
Andreasen, N.C., Arndt, S., Alliger, R., Miller, D. and Flaum, M. (1995) Arch.Gen.Psychiatry 52, 341–351.
Hafner, H. and an, d.H. (1997) Can.J.Psychiatry 42, 139–151.
Lieberman, J.A., Sheitman, B., Chakos, M., Robinson, D., Schooler, N. and Keith, S. (1998) J.CIin.Psychopharmacol. 18, 20S–24S.
Wiersma, D., Nienhuis, F.J., Slooff, C.J. and Giel, R. (1998) Schizophr.Bull. 24, 75–85.
Lieberman, J., Jody, D., Geister, S., Alvir, J., Loebel, A., Szymanski, S., Woerner, M. and Borenstein, M. (1993) Arch.Gen.Psychiatry 50, 369–376.
Lieberman, J.A. (1993) J.Clin.Psychiatry 54 Supp1:13–7, 13–7.
Huber, G. (1997) Schizophr.Res. 28, 177–185.
Kendler, K.S. and Gardner, C.O. (1997) Psychol.Med. 27, 411–419.
Cardno, A.G., Marshall, E.J., Coid, B., MacDonald, A.M., Ribchester, T.R., Davies, N.J., Venturi, P., Jones, L.A., Lewis, S.W., Sham, P.C., Gottesman, I.I., Farmer, A.E., McGuffin, P., Reveley, A.M. and Murray, R.M. (1999) Arch.Gen.Psychiatry 56, 162–168.
Lewis, D.A. (1997) Neuropsychopharmacology. 16, 385–398.
Weinberger, D.R. (1987) Arch.Gen.Psychiatry 44, 660–669.
Murray, R.M., O’Callaghan, E., Castle, D.J. and Lewis, S.W. (1992) Schizophr.Bull. 18, 319332.
Murray, R.M. and Lewis, S.W. (1987) Br.Med.J.(CIin.Res.Ed.) 295, 681–682.
Goldman-Rakic, P.S. and Selemon, L.D. (1997) Schizophr.Bull. 23, 437–458.
Harrison, P.J. (1999) Brain 122, 593–624.
McCarley, R.W., Wible, C.G., Frumin, M., Hirayasu, Y., Levitt, J.J., Fischer, I.A. and Shenton, M.E. (1999) Biol.Psychiatry 45, 1099–1119.
Buckley, P.F. (1998) J.Nerv.Ment.Dis. 186, 79–86.
Cannon, M., Jones, P., Huttunen, M.O., Tanskanen, A., Huttunen, T., Rabe-Hesketh, S. and Murray, R.M. (1999) Arch.Gen.Psychiatry 56, 457–463.
Malmberg, A., Lewis, G., David, A. and Allebeck, P. (1998) Br.J.Psychiatry 172:308–13; discussion 308–13, 308–13.
Mednick, S.A., Huttunen, M.O. and Machon, R.A. (1994) Schizophr.Bull. 20, 263–267.
O’Callaghan, E., Sham, P.C., Takei, N., Murray, G., Glover, G., Hare, E.H. and Murray, R.M. (1994) Br.J.Psychiatry 165, 353–356.
Susser, E.S. and Lin, S.P. (1992) Arch.Gen.Psychiatry 49, 983–988.
Hollister, J.M., Laing, P. and Mednick, S.A. (1996) Arch.Gen.Psychiatry 53, 19–24.
Selten, J.P., van der Graaf, Y., van Duursen, R., Gispen-de Wied, C.C. and Kahn, R.S. (1999) Schizophr.Res. 35, 243–245.
van Os, J. and Selten, J.P. (1998) Br.J.Psychiatry 172:324–6, 324–6.
Lipska, B.K., Jaskiw, G.E. and Weinberger, D.R. (1993) Neuropsychopharmacology. 9, 67–75.
Wood, G.K., Lipska, B.K. and Weinberger, D.R. (1997) Brain Res.Dev.Brain Res. 101, 17–25.
Castle, D., Sham, P. and Murray, R. (1998) Schizophr.Res. 33, 179–183.
Loebel, A.D., Lieberman, J.A., Alvir, J.M., Mayerhoff, D.I., Geister, S.H. and Szymanski, S.R. (1992) Am.J.Psychiatry 149, 1183–1188.
Huber G, Gross G, Shuttler, R. and Linz M (1980) Schizophr.Bull. 6, 592–605.
May, P.R., Tuma, A.H., Dixon, W.J., Yale, C., Thiele, D.A. and Kraude, W.H. (1981) Arch.Gen.Psychiatry 38, 776–784.
Wyatt, R.J., Green, M.F. and Tuma, A.H. (1997) Psychol.Med. 27, 261–268.
Wyatt, R.J. (1991) Schizophr.Res. 5, 201–202.
Lieberman, J.A. (1999) J.Clin.Psychiatry 60 Suppl 12:9–12, 9–12.
Gur, R.E., Cowell, P., Turetsky, B.I., Gallacher, F., Cannon, T., Bilker, W. and Gur, R.C. (1998) Arch.Gen.Psychiatry 55, 145–152.
DeLisi, L.E., Sakuma, M., Tew, W., Kushner, M., Hoff, A.L. and Grimson, R. (1997) Psychiatry Res. 74, 129–140.
Rapoport, J.L., Giedd, J., Kumra, S., Jacobsen, L., Smith, A., Lee, P., Nelson, J. and Hamburger, S. (1997) Arch.Gen.Psychiatry 54, 897–903.
Jacobsen, L.K., Giedd, J.N., Vaituzis, A.C., Hamburger, S.D., Rajapakse, J.C., Frazier, J.A., Kaysen, D., Lenane, M.C., McKenna, K., Gordon, C.T. and Rapoport, J.L. (1996) Am.J.Psychiatry 153, 355–361.
Rapoport, J.L., Giedd, J.N., Blumenthal, J., Hamburger, S., Jeffries, N., Fernandez, T., Nicolson, R., Bedwell, J., Lenane, M., Zijdenbos, A., Paus, T. and Evans, A. (1999) Arch.Gen.Psychiatry 56, 649–654.
Nair, T.R., Christensen, J.D., Kingsbury, S.J., Kumar, N.G., Terry, W.M. and Garver, D.L. (1997) Psychiatry Res. 74, 141–150.
Lieberman, J.A., Alvir, J.M., Koreen, A., Geisler, S., Chakos, M., Sheitman, B. and Woerner, M. (1996) Neuropsychopharmacology. 14, 13S–21S.
Kraus JE and McNamara JO (1995) Cur Op Neurobiology 5, 358–366.
Moises HW, Yang L, Kristbjarnarson H and et al (1995) Nature Genetics 11, 321–324.
Moldin SO (1997) Nature Genetics 17, 127–129.
Levinson DF, Mahtani MM, Nancarrow DJ and et al (1998) American Journal of Psychiatry 155, 741–750.
Shoulson I (1998) Science 282, 1072–1074.
Sohal RS, Ku H-H, Agarwal S, Forster MJ and Lai H (1994) Mech Aging Dev 74, 121–133.
Stevens JR (1997) Schizophrenia Bulletin 23, 373–383.
Prohovnik I, Dwork AJ, Kaufman MA and Willson N (1993) Schizophrenia Bulletin 19, 805816.
Wallace DC (1999) Science 283, 1482–1488.
Whatley SA, Curti D and Marchbanks RM (1996) Neurochem Res 21, 995–1004.
Whatley SA, Curti, D, Das Gupta F, Ferrier IN, Jones S, Taylor C and Marchbanks RM (1998) Mol Psychiatry 3, 227–237.
Sagara Y (1998) JNeurochem 71, 1002–1012.
Stoffel M, Karayiorgou M, Espinosa R and Beau MM (1996) Human Genetics 98, 113–115.
Hetts Sw (1998) JAMA 279, 300–307.
Vito P, Lacana E and D’Adamio L (1996) Science 271, 521–525.
Wolozin B, Iwasaki K and Vito P (1996) Science 274, 1710–1713.
Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M and Przedborski S (1997) Science 277,559–562.
Margolis RL, Chuang DM and Post RM (1994) Biological Psychiatry 35, 946–956.
Lieberman J.A. Is Schizophrenia a Neurodegenerative Disorder: A Clinical and Pathophysiological Perspective. Biological Psychiatry In Press
Whitney KD and McNamara JO (1999) Annu Rev Neurosci 22, 175–195.
Swedo, S.E., Leonard, H.L., Garvey, M., Mittleman, B., Allen, A.J., Perlmutter, S., Lougee, L., Dow, S., Zamkoff, J. and Dubbert, B.K. (1998) Am.J.Psychiatry 155, 264–271.
March, J.S., Leonard, H.L. and Swedo, S.E. (1995) Compr.Ther. 21, 507–512.
Andrews PI and McNamara JO (1996) Curr Opin Neurobiol 6, 673–678.
McNamara JO, Patel M, He XP, Janumpalli S and Whitney KD (1996) Cold Spring Harb Symp Quant Biol 61, 327–332.
Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B, Hughes TE, Heinemann SF and McNamara JO (1994) Science 265, 648–651.
Andrews PI, Dichter MA, Berkovic SF, Newton MR and McNamara JO (1996) Neurology 46, 242–246.
He XP, Patel M, Whitney KD, Tenner A and McNamara JO (1998) Neuron 20, 153–163.
Kirch DG (1993) Schizophrenia Bulletin 19, 355–370.
Jones P and Cannon M (1998) Psychiatr Clin North Am 21, 1–25.
Ganguli R, Brar JS and Rabin BS (1994) Hary Rev Psychiatry 2, 70–83.
Ganguli R, Brar JS, Chengappa KN and Yang ZW (1993) Ann Med 25, 489–496.
Noy S, Achiron A and Laor N (1994) Neuropsychobiology 30, 157–159.
Schwarz MJ, Riedel M, Gruber R, Ackenheil M and Muller N (1999) Am J Psychiatry 156, 1103–1104.
Cadet JL and Kahler LA (1994) Neuroscience and Biobehavioral Reviews 18, 457–467.
Reddy RD and Yao JK (1996) Prostaglandins, Leukotrienes and Essential Fatty Acids 55, 33–43.
Borg DC and Schaich KM (1988) in Free Radicals and Tissue Injury (Halliwell B, ed.), pp. 2026, FASEB Press Rockville, Bethesda.
Mahadik, S.P. and Scheffer, R.E. (1996) Prostaglandins Leukot.Essent.Fatty Acids. 55, 45–54.
Lafton-Cazal M, Pietri S, Culcasi M and Bockaert J (1993) Nature 364, 535–537.
Culcasi M, Lafton-Cazal M, Pietri S and Bockaert J (1994) J Biol Chem 269, 12589–12593.
Bredt DS and Snyder SH (1994) Annu Rev Biochem 63, 175–195.
Bohme GA, Bon C, Stutzmann JM, Doble A and Blanchard JC (1991) Eur J Pharmacol 199, 379–381.
O’Dell TJ, Hawkins RD, Kandel ER and Arancio O (1991) Proc Natl Acad Sci USA 88, 11285–11289.
Haley JE, Wilcox GL and Chapman PF (1992) Neuron 8, 211–216.
Schuman EM and Madison DV (1994) Annu Rev Neurosci 17, 153–183.
Dawson VL, Dawson TM, London ED, Bredt DS and Snyder SH (1991) Proc Natl Acad Sci USA 88, 6368–6371.
Rubin E and Farber JL (1988) in Pathology (Rubin E and Farber JL, eds.), pp. 2–33, J.B. Lippincott Company, Philadelphia.
Mahadik SP, Mukherjee S, Scheffer RE, Correnti EE and Mahadik JS (1998) Biological Psychiatry 43, 674–679.
Graham DG, Tiffany SM, Bell WR and Gutknecht WF (1978) Mol Pharm 14, 644–653.
Stamler, J.S. and Piantadosi, C.A. (1996) J.Clin.Invest. 97, 2165–2166.
Mahadik SP and Scheffer RE (1996) Prostaglandins, Leukotrienes and Essential Fatty Acids 55, 45–54.
Smythies, J.R. (1997) Schizophr.Res. 24, 357–364.
Graham DG (1978) Mol Pharm 14, 633–643.
Miyakawa T, Sumiyoshi S, Deshimaru M, Suzuki T, Tomonari H, Yasouka F and Tatetsu S (1972) Acta Neuropathol 20, 67–77.
Abdalla, D.S., Monteiro, H.P., Oliveira, J.A. and Bechara, E.J. (1986) Clin.Chem. 32, 805–807.
Yao JK, Reddy R, McElhinny LG and van Kammen DP (1999) Schizophrenia Research 32, 1–8.
Mukherjee S, Mahadik SP, Scheffer RE, Correnti EE and Kelkar H (1996) Schizophrenia Research 19, 19–26.
Yao JK,.Reddy R, McElhinny LG and van Kammen DP (1999) Journal of Psychiatric Research 32, 385–391.
Das, I., Ramchand, C.N., Gliddon, A. and Hirsch, S.R. (1998) Neuropsychobiology 37, 65–67.
Lohr, J.B. and Lavori, P. (1998) Biol.Psychiatry 43, 861–862.
McCreadie, R.G., MacDonald, E., Wiles, D., Campbell, G. and Paterson, J.R. (1995) Br.J.Psychiatry 167, 610–617.
Suboticanec K, Folnegovic V, Korbar M, Mestrovic B and Buzina R (1990) Biol Psychiatry 28, 959–966.
Patel M (1996) Mol Psychiatry 1, 362–363.
Day BJ, Batinic-Haberle I and Crapo JD (1999) Free Radic Biol Med 26, 730–736.
Dingledine R, Borges K, Bowie D and Traynelis SF (1999) Pharmacol Rev 51, 7–61.
Anwyl R (1999) Brain Res Brain Res Rev 29, 83–120.
Coyle JT (1996) Hary Rev Psychiatry 3, 241–253.
Farber NB, Newcomer JW and Olney JW (1999) Arch Gen Psychiatry 56, 13–17.
Zorumski CF and Izumi Y (1998) Prog Brain Res 118, 173–182.
Ungerer A, Mathis C and Melan C (1998) Exp Brain Res 123, 45–51.
Javitt DC and Zukin SR (1991) Am J Psychiatry 148, 1301–1308.
Lodge D and Anis NA (1992) Eur J Pharmacol 77, 203–204.
Anis NA, Berry SC, Burton NR and Lodge D (1983) Br J Pharmacol 79, 565–575.
Olney JW and Farber NB (1995) Arch Gen Psychiatry 52, 998–1007.
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB and Charney DS (1994) Arch Gen Psychiatry 51, 199–213.
Malhotra AK, Pinals DA, Weingartner H, Sirocco K, Missar CD, Pickar D and Breier A (1996) Neuropsychopharmacology 14, 301–307.
Adler, L.E., Olincy, A., Waldo, M., Harris, J.G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S. and Freedman, R. (1998) Schizophr.Bull. 24, 189–202.
Lahti AC, Koffel B, LaPorte D and Tamminga CA (1995) Neuropsychopharmacology 13, 9–19.
Malhotra AK, Pinals DA, Adler CM, Elman I, Clifton A, Pickar D and Breier A (1997) Neuropsychopharmacology 17, 141–150.
Heresco-Levy U, Silipo G and Javitt DC (1996) Psychopharm Bull 32, 731–740.
Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G and Lichtenstein M (1999) Arch Gen Psychiatry 56, 29–36.
van Berckel BNM, Hijman R, van der Linden JA, Westenberg HGM, van Ree JM and Kahn RS (1996) Biol Psychiatry 40, 1298–1300.
Tsai G, Yang P, Chung L-C, Lange N and Coyle JT (1998) Biol Psychiatry 44, 1081–1089.
Goff DC, Tsai G, Levitt J, Amico E, Manoach D, Schoenfeld DA, Hayden DL, McCarley R and Coyle JT (1999) Arch Gen Psychiatry 56, 21–27.
Tamminga CA (1999) Br J Psychiatry Suppl 37, 12–15.
Carlsson A, Hansson LO, Waters N and Carlsson ML (1999) Br J Psychiatry Suppl 37, 2–6.
Olney JW, Labruyere J and Price MT (1989) Science 244, 1360–1362.
Olney JW, Labruyere J, Wang G, Sesma MA, Wozniak DF and Price MT (1991) Science 254, 1515–1518.
Hargreaves RJ, Rigby M, Smith D, Hill RG and Iversen LL (1993) Neurochem Res 18, 1263–1269.
Olney JW (1994) Psychopharmacol Bull 30, 533–540.
Fix AS, Wightman KA and O’Callaghan JP (1995) Neurotoxicology 16, 229–239.
Hasegawa M, Kinoshita H, Amano M, Hasegawa T, Kameyama T and Nabeshima T (1993) Neurosci Lett 150, 53–56.
Moghaddam B, Adams B, Verma A and Daly D (1997) J Neurosci 18, 5545–5554.
Farber NB and Olney JW (1995) Neuropsychopharmacology 12, 347–349.
Newcomer JW, Farber NB, Selke G, Melson AK, Jevtovic-Todorovic V and Olney JW (1998) Soc Neurosci Abstr 24, 525
Jevtovic-Todorovic V, Olney JW and Farber NB (1998) Soc Neurosci Abstr 24, 745
Anand A, Charney DS, Berman RM, Oren DA, Cappiello A and Krystal JH (1997) Soc Neurosci Abstr 23, 1755
Farber NB, Hanslick J, Kirby C, McWilliams L and Olney JW (1998) Neuropsychopharmacology 18, 57–62.
Lieberman JA, Mailman RB, Duncan G, Sikich L, Chakos M, Nichols DE and Kraus JE (1998) Biol Psychiatry 44, 1099–1117.
Richelson E (1999) J Clin Psychiatry 60 (suppl 10), 5–14.
Moghaddam B and Adams B (1998) Science 281, 1349–1352.
Patel M, Day BJ, Crapo JD, Fridovich I and McNamara JO (1996) Neuron 16, 345–355.
Perez-Velazquez JL, Frantseva MV and Carlen PL (1997) J Neurosci 17, 9085–9094.
Prehn JH (1998) Naunyn Schmiedebergs Arch Pharmacol 357, 316–322.
Clement MV and Pervaiz S (1999) Free Radic Res 30, 247–252.
Ikeda K, Kajiwara K, Tanabe E, Tokumaru S, Kishida E, Masuzawa Y and Kojo S (1999) Biochem Pharmacol 57, 1361–1365.
Ikeda M, Kodama H, Fukuda J, Shimizu Y, Murata M, Kumagai J and Tanaka T (1999) Biol Reprod 61,393–399.
Esteve JM, Mompo J, Garcia de la Asuncion J, Sastre J, Asensi M, Boix J, Vina JR, Vina J and Pallardo FV (1999) FASEB J 13, 1055–1064.
Tagami M, Ikeda K, Yamagata K, Nara Y, Fujino H, Kubota A, Numano F and Yamori Y (1999) Lab Invest 79, 609–615.
Kim YH, Kim EY, Gwag BJ, Sohn S and Koh JY (1999) Neuroscience 89, 175–182.
Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L and Olney JW (1999) Science 283, 70–74.
Mahadik, S.P. and Mukherjee, S. (1996) Schizophr.Res. 19, 1–17.
Lieberman JA, Sheitman BB and Kinon BJ (1997) Neuropsychopharmacology 17, 205–229.
Kraus JE, Yeh G-C, Nadler JV and McNamara JO (1994) J Neurosci 14, 4196–4205.
Kraus JE and McNamara JO (1995) in The Cortical Neuron (Gutnick MJ and Mody I, eds.), pp. 264–275, Oxford University Press, New York.
Martin D, McNamara JO and Nadler JV (1993) J Neurosci 12, 1928–1935.
Kohr G, De Koninck and Mody I (1993) J Neurosci 13, 3612–3627.
Kohr G and Mody J(1994) Neuroscience 62, 975–981.
Nadler JV, Thompson MA and McNamara JO (1994) Neuropharm 33, 147–153.
Kraus JE, Nadler JV and McNamara JO (1996) Mol Brain Res 41, 97–104.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kraus, J., Perkins, D.O., Lieberman, J.A. (2001). Pathophysiology of Schizophrenia. In: Miller, T., Mednick, S.A., McGlashan, T.H., Libiger, J., Johannessen, J.O. (eds) Early Intervention in Psychotic Disorders. NATO Science Series, vol 91. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0892-1_12
Download citation
DOI: https://doi.org/10.1007/978-94-010-0892-1_12
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-6750-5
Online ISBN: 978-94-010-0892-1
eBook Packages: Springer Book Archive